An integrative multi-omics analysis leveraging Mendelian randomization and subsequent experimental validation prioritizes glutathione S-transferase mu 5 (GSTM5) as a genomic stability-related gene and a therapeutic vulnerability to PLK1 inhibition in breast cancer
Author:
He Ma,Tiankang Li,Runcheng Huang,Yaping Liu,Lei Zhao,Zhigang Zhuang
Publication:
International Journal of Biological Macromolecules
© 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.